Pisapia joined Adept in January 2007 as general manager, with a technology and engineering background and having enjoyed a successful career in sales, marketing and product development. His expertise in data acquisition, test and measurement, process control, mathematics and simulation software, as well as strategic planning and business systems, will continue to drive Adept Scientific forward and further strengthen its position as a multi-source supplier of hardware and software for technical computing applications.
‘I relish the challenge of ensuring that Adept Scientific continues its long story of success,’ he said. ‘I'm obviously delighted at the confidence Paul and the rest of the board have shown in me and it's up to me to prove they've made the right decision.’
New managing director for Adept Scientific
Mike Pisapia takes over from co-founder Paul Bragg who becomes chairman
You may also like
Digital
![Shilpa Biologicals launches PartnerPower real-time visibility platform for biologics CDMO operations]()
Shilpa Biologicals launches PartnerPower real-time visibility platform for biologics CDMO operations
The digital data fabric links R&D, analytical development and GMP manufacturing, replacing periodic reporting with continuous audit-ready transparency aligned to FDA, EMA and PMDA expectations
Digital
![TXP secures £1.5m MHRA contract for cloud architecture and cyber security services]()
TXP secures £1.5m MHRA contract for cloud architecture and cyber security services
The deal extends TXP's existing MHRA partnership, supporting the regulatory agency's digital modernisation through infrastructure development and knowledge transfer as TXP expands its UK public sector footprint
Digital
![Camgenium launches pre-certified Foundation Platform for connected medical device development]()
Camgenium launches pre-certified Foundation Platform for connected medical device development
The infrastructure combines IEC 62304-compliant firmware, ISO 27001 cloud hosting and automated regulatory reporting, letting OEM teams focus engineering effort on clinical differentiation rather than compliance build-out
Digital
![ZoBio launches integrated DEL hit discovery service for challenging drug targets]()
ZoBio launches integrated DEL hit discovery service for challenging drug targets
The new library-agnostic platform combines DEL screening with X-ray crystallography, quantitative biophysics and off-DNA validation, delivering structurally characterised, progressible starting points beyond conventional hit identification
Digital
![Cytiva launches next-generation Biacore 8 SPR systems for accelerated drug discovery]()
Cytiva launches next-generation Biacore 8 SPR systems for accelerated drug discovery
The company has introduced its new Biacore 8S and 8S+ surface plasmon resonance systems, combining high-throughput screening, molecular characterisation and automated workflows to support faster and more confident drug discovery
Digital
![ByteSnap Design and Digi International partner to deliver SBOM-driven cybersecurity compliance for medical devices]()
ByteSnap Design and Digi International partner to deliver SBOM-driven cybersecurity compliance for medical devices
ByteSnap Design has announced a collaboration with Digi International to offer a managed security service for connected medical and industrial IoT devices to support compliance with FDA cybersecurity mandates and the EU Cyber Resilience Act